Clinical trials
Gastric clinical trials
Below are recruiting gastric clinical trials, each written for real people, not researchers. We’re tracking 850 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07023848Enrolling by invitationEarly Phase 1
Imaging study for HER2-positive cancers using a special tracer
This study uses a radioactive tracer to take pictures of tumors that have a protein called HER2. It may help doctors see where the cancer is in your body and could guide future treatment decisions.
Wuxi, JiangsuAges 18–75 - NCT07023315RecruitingPhase 3
Study of cadonilimab plus SOX before and after surgery for stomach cancer
This trial tests if adding the drug cadonilimab to standard chemotherapy (SOX) before and after surgery can help treat stomach or gastroesophageal junction cancer that can be removed. The goal is to see if this combination improves outcomes for patients.
Beijing, Beijing MunicipalityAges 18–75 - NCT07015424Recruiting
Procedure to help with weight regain after gastric bypass
This study tests a procedure called TORe that tightens the opening between the stomach pouch and the intestine to help people who have regained weight after gastric bypass surgery. It also includes lifestyle changes to support long-term weight control.
Irvine, CaliforniaAges 18 years+ - NCT07022951Recruiting
Million Anesthesia Cases Study on Preoperative Fasting
This study looks at how fasting before anesthesia affects recovery for people having procedures. Researchers want to understand what happens to patients when they have nothing to eat or drink before anesthesia.
Boston, MassachusettsAges Any age - NCT05450835Recruiting
Surgery technique comparison for stomach cancer near the esophagus
This study compares two ways surgeons reconnect the digestive tract after removing the whole stomach for certain stomach cancers near the esophagus. It aims to see which technique is safer and leads to better recovery and outcomes.
Quanzhou, FujianAges 18–75 - NCT07006142Recruiting
Fasting time and stomach volume for GLP-1 patients
This trial studies how a longer fasting period affects stomach contents in people taking GLP-1 receptor agonists (a type of diabetes or weight-loss drug). It helps doctors understand if extra fasting time is needed before an upper endoscopy (a camera test for the stomach).
Rochester, MinnesotaAges 18 years+ - NCT06199895RecruitingPhase 2
Study of paclitaxel for patients with taxane-resistant solid tumors
This trial tests paclitaxel given as tiny micelle particles for people whose cancer (pancreatic, bile duct, lung, stomach, esophagus, or breast) stopped responding to taxane chemotherapy or did not shrink. The goal is to see if this treatment can help when standard taxanes no longer work.
Wuhan, HubeiAges 18 years+ - NCT06995898Recruiting
Blood test study for early cancer detection
This study is testing a new blood test that may help find cancer early. You will give blood samples over a year, and researchers will check them for signs of cancer.
Pleasanton, CaliforniaAges 45–75 - NCT06999187RecruitingPhase 1
Study of DR-0202 for advanced solid tumors after multiple treatments
This trial tests a new drug, DR-0202, for people with certain advanced cancers that have not responded to at least two prior treatments. It may be an option if standard treatments are no longer working.
Denver, ColoradoAges 18 years+ - NCT06413212Recruiting
Personalized drug test for advanced cancer with fluid buildup
This trial uses a special test on your cancer cells to find which chemotherapy might work best for you. The aim is to treat advanced cancer that has caused fluid buildup in the chest or abdomen.
Wuhan, HubeiAges 18 years+ - NCT06993402Enrolling by invitation
Düsseldorf ESD Study
This study is testing the use of ESD, a procedure to remove abnormal tissue from your digestive tract using a thin, flexible scope. It may be an option if you need this procedure in your esophagus, stomach, duodenum, colon, or rectum.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT06696209Recruiting
Best way to measure time during an upper GI endoscopy
This trial compares two ways of measuring time during an upper GI endoscopy (a camera test that looks at your esophagus, stomach, and the start of your small intestine) to see which one helps doctors find possible cancers better. The goal is to improve how these exams are done for people who need them for diagnosis or monitoring.
CoimbraAges 18 years+ - NCT06984952Recruiting
ERAS program for recovery after minimally invasive stomach cancer surgery
This study tests whether a special care program called ERAS (Enhanced Recovery After Surgery) helps people recover better and faster after keyhole surgery for stomach cancer. It aims to improve your hospital experience and reduce complications.
BusanAges 19 years+ - NCT06988475RecruitingPhase 2/Phase 3
Capmatinib for cancers with MET gene changes
This study tests an oral drug called capmatinib for people whose cancers have specific changes in the MET gene (except for one type of lung cancer). It aims to see if the drug can shrink tumors or slow their growth.
BelfastAges 18 years+ - NCT06974110RecruitingPhase 1
Study of a new drug for advanced solid tumors with MSI-H or dMMR
This trial tests an oral medication called MOMA-341 in people with advanced solid tumors that have high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR). It aims to see if the drug can help when prior immunotherapy hasn't worked or isn't available.
Phoenix, ArizonaAges 18 years+ - NCT06870630Recruiting
Comparing two myotomy methods for type 2 achalasia
This trial tests two muscle-cutting procedures for people newly diagnosed with type 2 achalasia (a swallowing disorder). The goal is to see if a more complex myotomy works better than the standard one.
Hyderabad, TelanganaAges 18–75 - NCT06967571Recruiting
Rebuilding the digestive tract after stomach removal
This trial tests a new way to rebuild the connection between the esophagus and small intestine after total stomach removal. It creates a pouch from the jejunum (part of the small intestine) to help with eating and digestion.
RomaAges 18–75 - NCT05838300Recruiting
Compare special air flow methods during gastric bypass surgery
This trial compares two ways of delivering and removing carbon dioxide gas during minimally invasive gastric bypass and related hiatal hernia repair surgery. It looks at whether one method is safer or more comfortable by changing how the gas is warmed, humidified, and controlled.
Houston, TexasAges 18–65 - NCT06951893Recruiting
Predicting quality of life after weight-loss surgery
This study looks at whether certain traits before weight-loss surgery can predict how a person's quality of life will change afterward. It aims to find patterns that could help doctors and patients make better decisions about treatment.
Chambéry, SavoieAges 18 years+ - NCT06949033RecruitingPhase 3
Cadonilimab with chemo for stomach cancer
This trial tests a new combination of immunotherapy (cadonilimab) and chemotherapy before and after surgery for a specific type of advanced stomach or gastroesophageal junction cancer. It aims to see if adding this immunotherapy helps shrink tumors and improve outcomes.
Lanzhou, GansuAges 18–75 - NCT06943521RecruitingPhase 1/Phase 2
Study of MT-4561 for advanced solid tumors
This trial tests a new drug called MT-4561 in people with advanced solid tumors that have not responded to prior treatments. It aims to see if the drug can help shrink tumors or slow their growth.
Los Angeles, CaliforniaAges 18 years+ - NCT06941545Recruiting
Stomach mapping study for functional dyspepsia
This study uses a special stomach mapping technique and a tube to measure stomach activity in people with functional dyspepsia (long-term stomach discomfort or pain). The goal is to better understand how the stomach works, which could help improve future treatments.
Rochester, MinnesotaAges 18–80 - NCT06937567RecruitingEarly Phase 1
CDH17 car-t therapy for advanced solid tumors
This trial tests a new treatment called CDH17 CAR-T for people with advanced solid tumors like colorectal, stomach, pancreatic, or bile duct cancer. It is for patients who have tried other treatments without success. The therapy uses your own immune cells, modified to target a protein called CDH17 found on some cancer cells.
Hangzhou, ZhejiangAges 18–70 - NCT06766305RecruitingPhase 1/Phase 2
QL1706 combined with SOX before and after stomach cancer surgery
This trial tests a new combination of drugs (QL1706 plus chemotherapy SOX) given before and after surgery for stomach or gastroesophageal junction cancer. It aims to shrink the tumor before surgery and help prevent recurrence afterward.
Hangzhou, ZhejiangAges 18–75
Hear when a new Gastric trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastric?
- Yes. Clin2 currently lists 850 recruiting gastric studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastric trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastric trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.